ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,099.96
      1.02%
      US Tech 100
      17,244.40
      1.57%
      Dow Jones
      38,239.66
      0.40%
      Brent Oil
      88.165
      0.02%
      Bitcoin
      63,977.28
      -0.79%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Calliditas Therapeutics AB (CALT)

      7. Calliditas Therapeutics AB (CALT) News

      CALT Calliditas Therapeutics AB

      19.5006
      0.0506 (0.26%)
      After Hours
      Last Updated: 16:04:47
      Delayed by 15 minutes
      Company Name Stock Ticker Symbol Market Type
      Calliditas Therapeutics AB CALT NASDAQ Depository Receipt
        Price Change Change Percent Stock Price Last Traded
      Upgrade Icon
      0.0506 0.26% 19.5006 16:04:47
      Open Price Low Price High Price Close Price Prev Close
      19.50 18.4842 20.1499 19.5006 19.45
      more quote information »

      Recent News

      Date Time Source Heading
      4/24/202413:35PRNUSCalliditas Therapeutics' 2023 Annual Report Published
      4/24/202413:26PRNUSCalliditas Therapeutics' 2023 Annual Report Published
      4/24/202403:30PRNUSCalliditas Announces Positive NefIgArd Open Label Extension..
      4/24/202403:26PRNUSCalliditas Announces Positive NefIgArd Open Label Extension..
      4/18/202407:13PRNUSCalliditas Therapeutics Presents Additional Data Analyses..
      4/18/202407:10PRNUSCalliditas Therapeutics Presents Additional Data Analyses..
      4/09/202407:24PRNUSCalliditas Therapeutics to Attend Conferences in April
      4/09/202407:22PRNUSCalliditas Therapeutics to Attend Conferences in April
      4/08/202408:38PRNUSCalliditas Therapeutics to Present Nefecon Data at the ISN..
      4/08/202408:32PRNUSCalliditas Therapeutics to Present Nefecon Data at the ISN..
      4/08/202403:24PRNUSCalliditas receives notice of allowance for United States..
      4/08/202403:22PRNUSCalliditas receives notice of allowance for United States..
      3/11/202421:28PRNUSEverest Medicines' Partner Calliditas Therapeutics Announces..
      3/06/202402:38PRNUSCalliditas announces an additional seven year orphan drug..
      3/06/202402:34PRNUSCalliditas announces an additional seven year orphan drug..
      3/01/202407:43PRNUSCalliditas Therapeutics to Attend Investor Conferences in..
      3/01/202407:39PRNUSCalliditas Therapeutics to Attend Investor Conferences in..
      2/21/202401:45PRNUSCalliditas Year-end report, January - December 2023
      2/21/202401:43PRNUSCalliditas Year-end report, January - December 2023
      2/14/202401:11PRNUSInvitation to the presentation of Calliditas´ Year-end..
      2/14/202401:09PRNUSInvitation to the presentation of Calliditas´ Year-end..
      2/13/202411:28PRNUSCalliditas provides patent update
      2/13/202411:26PRNUSCalliditas provides patent update
      1/08/202408:28EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      1/08/202402:33PRNUSCalliditas Therapeutics provides business update ahead of JP..
      1/08/202402:31PRNUSCalliditas Therapeutics provides business update ahead of JP..
      1/07/202411:21PRNUSCalliditas Therapeutics appoints Maria Törnsén as President..
      1/07/202411:19PRNUSCalliditas Therapeutics appoints Maria Törnsén as President..
      1/07/202411:07PRNUSCalliditas to present at JP Morgan Healthcare Conference
      1/07/202411:05PRNUSCalliditas to present at JP Morgan Healthcare Conference
      12/27/202316:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      12/27/202312:22PRNUSCalliditas refinances existing term loan with Euro 92..
      12/27/202312:16PRNUSCalliditas refinances existing term loan with Euro 92..
      12/20/202319:00DJNStocks to Watch: Micron, Warner Bros. Discovery, Paramount..
      12/20/202317:33DJNCalliditas Therapeutics Shares Rise 33% After FDA Approves..
      12/20/202317:13EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      12/20/202316:34PRNUSCalliditas Therapeutics announces full FDA approval of..
      12/20/202316:33PRNUSCalliditas Therapeutics announces full FDA approval of..
      12/11/202309:40PRNUSCalliditas Receives Notice of Allowance for United States..
      12/11/202309:38PRNUSCalliditas Receives Notice of Allowance for United States..
      12/01/202303:27PRNUSCalliditas announces additions to the management team
      12/01/202303:21PRNUSCalliditas announces additions to the management team
      11/30/202302:55PRNUSCalliditas initiates clinical study to evaluate setanaxib in..
      11/30/202302:49PRNUSCalliditas initiates clinical study to evaluate setanaxib in..
      11/24/202303:13PRNUSCalliditas' partner Everest Medicines announces China NMPA's..
      11/24/202303:10PRNUSCalliditas' partner Everest Medicines announces China NMPA's..
      11/07/202310:31PRNUSCalliditas to present at upcoming investor conferences
      11/07/202310:29PRNUSCalliditas to present at upcoming investor conferences
      11/07/202301:32PRNUSCalliditas Interim Report January - September 2023
      11/07/202301:29PRNUSCalliditas Interim Report January - September 2023

      Your Recent History

      NASDAQ
      CALT
      Calliditas Therapeutics AB
      Delayed Upgrade Clock